Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Maryland
Fierce Pharma
BioNTech to wind down cell therapy manufacturing in Maryland
After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.
Fraiser Kansteiner
Jun 18, 2025 10:23am
GSK to move vaccine R&D group from Maryland to Massachusetts
Feb 12, 2025 11:27am
Sirnaomics nabs a rare series E worth $105M
Jul 2, 2021 10:56am
OncoImmune nabs $56M round for late-stage COVID tests, leukemia
Sep 9, 2020 9:05am
AstraZeneca spinout bags $250M series A
Feb 28, 2018 8:51am
CDMO Pharmaceutics International gains $93M investment, new president
Sep 7, 2016 10:52am
